Detalhe da pesquisa
1.
A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.
Hematol Oncol
; 42(3): e3274, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38711253
2.
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
Blood
; 138(1): 11-22, 2021 07 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33827116
3.
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Clin Transl Sci
; 17(3): e13742, 2024 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38494922
4.
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.
Clin Cancer Res
; 29(1): 60-66, 2023 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36255372